Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Synthetic exendin-4 (AC2993): Began Phase Ib study

Amylin Pharmaceuticals Inc. (AMLN), San Diego,

Read the full 65 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE